Stockreport

NexImmune to Present at The Society for Immunotherapy of Cancer 36th Anniversary Annual Meeting

NexImmune, Inc.  (NEXI) 
PDF GAITHERSBURG, Md., Nov. 03, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherap [Read more]